Yatharth Hospital Share Price Target 2027: 13.5% Upside to Rs 1,154, Bull Case Rs 1,398
- November 6, 2026
- Posted by: Kunal Singla
- Category: Market
Yatharth Hospital share price Rs 1,017.10 (6 November 2026). Base target Rs 1,154, bull Rs 1,398, downside risk Rs 823. PE 54.55. 52W range Rs 538.25 to Rs 1,184.00.
Quick Answer
The Yatharth Hospital share price target for 2027 is Rs 1,154, about 13.5% above the current price of Rs 1,017.10. The bull case is Rs 1,398, and the downside risk level, which is not a target, is Rs 823. The base case assumes earnings per share grow 12.2% a year, the pace seen from FY24 to FY26, with the stock holding its PE of 54.55. These are model-based estimates built from reported financials, not guaranteed outcomes.
Investors weighing a Yatharth Hospital target price for 2027 should start with where the stock sits today. At Rs 1,017.10 on 6 November 2026, it is 14.1% below its 52-week high of Rs 1,184.00 and 89.0% above its 52-week low of Rs 538.25. That range spans 120% from low to high, so the entry point matters as much as the Yatharth Hospital price forecast itself.
This article builds the Yatharth Hospital share price target from reported numbers only: five years of annual results, the last five quarters, the latest shareholding pattern and current valuation ratios from company filings and exchange data. Each scenario states its assumptions, so you can trace how the base case, the bull case and the downside risk level were reached and test them against your own view.
Click Here – Get Free Investment Predictions
Yatharth Hospital Stock Analysis: Company Overview and Key Stats
Yatharth Hospital (NSE: YATHARTH) has a market capitalisation of Rs 9,908 crore. In FY26 it reported revenue of Rs 1,233 crore and net profit of Rs 170.31 crore. The table collects the figures the Yatharth Hospital share price target is built on.
| Metric | Value |
|---|---|
| Company | Yatharth Hospital |
| NSE Ticker | YATHARTH |
| CMP (6 November 2026) | Rs 1,017.10 |
| 52-Week High | Rs 1,184.00 |
| 52-Week Low | Rs 538.25 |
| Market Cap | Rs 9,908 crore |
| PE Ratio (TTM) | 54.55 |
| Industry PE | 63.24 |
| Price to Book | 5.28 |
| Return on Equity | 10.16% |
| Debt to Equity | 0.25 |
| EPS (TTM) | Rs 18.85 |
| Dividend Yield | 0.00% |
| 12-Month Base Target | Rs 1,154 |
| Bull Case | Rs 1,398 |
| Downside Risk Level (not a target) | Rs 823 |
Why Is Yatharth Hospital Share Price Target Set at Rs 1,154 for 2027?
The arithmetic is short. Trailing EPS of Rs 18.85 grown for one year gives a forward EPS estimate of Rs 21.15, and multiplying it by the unchanged PE of 54.55 gives the Rs 1,154 base-case Yatharth Hospital stock target. The bull case adds faster earnings growth and a higher multiple, while the downside risk level assumes flat earnings and a lower multiple.
Earnings Growth Behind the Yatharth Hospital Target Price: Five Years of Results
Yatharth Hospital grew revenue from Rs 402.59 crore in FY22 to Rs 1,233 crore in FY26, a compound annual growth rate of 32.3%. Net profit grew faster, from Rs 44.16 crore to Rs 170.31 crore (40.1% a year), which shows margin gains did part of the work and not just higher sales.
| Financial Year | Revenue (Rs Cr) | Net Profit (Rs Cr) | EPS (Rs) | Dividend per Share (Rs) |
|---|---|---|---|---|
| FY22 | 402.59 | 44.16 | 6.78 | 0.00 |
| FY23 | 523.10 | 65.77 | 10.09 | 0.00 |
| FY24 | 686.16 | 114.47 | 14.46 | 0.00 |
| FY25 | 896.66 | 130.55 | 14.72 | 0.00 |
| FY26 | 1,232.96 | 170.31 | 18.20 | 0.00 |
FY26 revenue growth was 37.5%, faster than the four-year average of 32.3%, and net profit moved up 30.5%. EPS rose from Rs 14.46 in FY24 to Rs 18.20 in FY26. The FY27 outlook depends on whether that EPS estimate keeps compounding.
Margins and the Latest Quarter
Yatharth Hospital converted 13.8% of FY26 revenue into net profit, against 14.6% in FY25, within a five-year range of 11.0% to 16.7%. EBITDA margin was 25.8% in FY26 versus 26.4% in FY25.
In the September 2026 quarter, revenue was Rs 436.44 crore, up 51.1% from the same quarter a year earlier, while net profit of Rs 48.46 crore was up 17.5%. EBITDA came in at Rs 107.04 crore, up 44.6% year on year. The next quarterly result is the first test of whether the earnings assumption holds.
Balance Sheet and Cash Flow
Debt to equity stands at 0.25, and shareholders’ equity grew from Rs 116.89 crore in FY22 to Rs 1,807 crore in FY26. Operating cash flow in FY26 was Rs 204.52 crore against capital expenditure of Rs 316.54 crore, leaving negative free cash flow of Rs 112.02 crore. In FY25 free cash flow was negative at Rs 170.76 crore.
Valuation Check for the Yatharth Hospital Stock Target: PE, Price to Book and ROE
At a PE of 54.55 against an industry PE of 63.24, Yatharth Hospital trades at a discount to its industry. Price to book is 5.28 on a book value of Rs 194.67 per share, and return on equity is 10.16%. A PE of 54.55 equals an earnings yield of 1.8%, and the FY26 dividend of Rs 0.00 per share gives a yield of 0.00%.
Shareholding Pattern and Institutional Holding
Promoters held 55.80% of Yatharth Hospital in September 2026, and promoter holding fell from 61.64% in September 2025 to 55.80% in September 2026. Foreign institutional investors (FII) held 7.05% and domestic institutions (DII) held 10.94%, which puts total institutional holding at 17.99%. FII holding rose from 6.50% in September 2025 to 7.05% in September 2026. Public shareholders own the remaining 26.21%. A meaningful institutional holding adds a layer of research coverage and trading depth.
Yatharth Hospital Share Price Targets for the Short Term and 12 Months
Short Term Yatharth Hospital Stock Target Levels: Technical Setup
At Rs 1,017.10 on 6 November 2026, Yatharth Hospital trades above its 50-day simple moving average of Rs 1,006.79 and above its 200-day exponential moving average of Rs 861.72. The 14-day RSI reads 54.8, which is neutral territory, and the MACD line sits above its signal line. The nearest resistance level is Rs 1,184.00 (52-week high) and the nearest support is Rs 1,006.79 (50-day simple moving average). A sustained move above Rs 1,184.00 would improve the short-term setup, while a close below Rs 1,006.79 would shift attention to the next support.
12 Month Yatharth Hospital Target Price for 2027
The 12-month target of Rs 1,154 means a move of 13.5% up from Rs 1,017.10 over the next 12 months. It would still leave the stock 2.5% below its 52-week high of Rs 1,184.00. Anyone checking the Yatharth Hospital share price target against their own view should focus on two inputs: the EPS estimate and the PE multiple.
How EPS Growth and PE Multiple Change the Yatharth Hospital Target Price
| EPS Growth | PE 43.64 | PE 54.55 | PE 62.73 |
|---|---|---|---|
| 0.0% (EPS Rs 18.85) | Rs 823 | Rs 1,028 | Rs 1,182 |
| 12.2% (EPS Rs 21.15) | Rs 923 | Rs 1,154 | Rs 1,327 |
| 18.2% (EPS Rs 22.28) | Rs 972 | Rs 1,215 | Rs 1,398 |
Each cell multiplies the forward EPS estimate by the PE shown. Reading across a row shows what a de-rating or re-rating does to the Yatharth Hospital price forecast, and reading down a column shows what earnings growth is worth at a fixed multiple.
Bull Case and Downside Risk for Yatharth Hospital Stock Target in 2027
Bull Case Rs 1,398
The bull case Yatharth Hospital price target needs EPS growth of 18.2%, which lifts forward EPS to Rs 22.28, and a PE multiple that rises 15% to 62.73. That gives Rs 1,398, 37.4% above the current price and above the 52-week high of Rs 1,184.00, so the stock would have to set a fresh 52-week high.
Downside Risk Level Rs 823
The downside risk level is not a target. It assumes EPS stays flat at Rs 18.85 and the PE falls 20% to 43.64. That gives Rs 823, 19.1% below the current price and above the 52-week low of Rs 538.25.
| Scenario | EPS Growth | PE Multiple | Price (Rs) | Change vs CMP |
|---|---|---|---|---|
| Bull Case | 18.2% | 62.73 | Rs 1,398 | +37.4% |
| Base Case | 12.2% | 54.55 | Rs 1,154 | +13.5% |
| Downside Risk | 0.0% | 43.64 | Rs 823 | -19.1% |
Key Risks to the Yatharth Hospital Target Price for 2027
Growth Slowdown Risk for the Yatharth Hospital Price Target
Revenue in the September 2026 quarter was up 51.1% year on year, and FY26 revenue growth was 37.5%. If growth slows from here, the EPS estimate behind the Yatharth Hospital stock target will need revising.
Liquidity and Size Risk
Yatharth Hospital has a market capitalisation of Rs 9,908 crore. Institutional holding is 17.99%, and promoters hold 55.80%. Stocks of this size can move sharply on small volumes, and exits can take longer than entries.
Valuation and Margin Risk
Net margin was 13.8% in FY26, and a squeeze from higher costs or weaker pricing would hit earnings first. At a PE of 54.55 versus an industry PE of 63.24, a de-rating toward the downside-risk PE of 43.64 would cut the price even if earnings hold.
Market and Technical Risk
Technical indicators add short-term risk: the 14-day RSI is 54.8 and the MACD sits above its signal line. A broad fall in the Nifty 50 or the Sensex can override company fundamentals for weeks at a time.
How to Invest in Yatharth Hospital
Start with the live price and volume. Any Yatharth Hospital share price target is only as current as the data behind it, and the data here is as of 6 November 2026, so refresh the Rs 1,017.10 price before acting on any level.
Next, review the fundamentals yourself. The Univest Screener lets you check Yatharth Hospital’s PE, ROE, debt and shareholding in one place.
Check Yatharth Hospital fundamentals on the Univest Screener
Then compare the three Yatharth Hospital target price scenarios with your own view. If you expect EPS growth below 12.2%, the base case is too optimistic for you; if you expect more, the bull case deserves weight.
Decide your position size and exit levels before you buy. The support and resistance levels above can serve as reference points, but they are not recommendations.
Finally, place the order through a SEBI-registered broker or the Univest app, and review the position after each quarterly result. Consult a SEBI-registered advisor if you are unsure.
Download the Univest iOS App or Univest Android App to track Yatharth Hospital live price and get daily stock recommendations.
Conclusion
The Yatharth Hospital share price target for 2027 is Rs 1,154 in the base case, with Rs 1,398 as the bull case. The support for that view is arithmetic you can check: EPS grew 12.2% a year over FY24 to FY26, and the stock trades at a PE of 54.55. The risks are equally concrete, including a valuation that can de-rate even when earnings hold and a downside scenario that cuts the price 19% if earnings stall. Use these numbers as a framework, check them against the latest filings, and size any position to your own risk appetite.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Yatharth Hospital Share Price Target 2027
What is the Yatharth Hospital share price target for 2027?
Ans. The base-case Yatharth Hospital share price target for 2027 is Rs 1,154, which is 13.5% above the price of Rs 1,017.10 on 6 November 2026. The bull case is Rs 1,398 and the downside risk level, which is not a target, is Rs 823. All three come from one method: forward EPS multiplied by a PE multiple, using only reported results. They are model estimates and not guaranteed outcomes, and the next quarterly result is the first check on the EPS assumption.
What is the Yatharth Hospital share price today?
Ans. As of 6 November 2026, 10:05 AM IST, Yatharth Hospital (NSE: YATHARTH) trades at Rs 1,017.10, down 0.99% on the day. That is 14.1% below the 52-week high of Rs 1,184.00 and 89.0% above the 52-week low of Rs 538.25. The market capitalisation of Rs 9,908 crore places it among small-cap stocks. Prices change through the trading session, so check the live quote before acting on any level in this article.
Is Yatharth Hospital a buy or sell at the current price?
Ans. The data points both ways. On the positive side, EPS has grown 12.2% a year over FY24 to FY26 and the base case implies 13.5% upside; on the cautious side, the valuation can de-rate even when earnings hold, and the downside risk level of Rs 823 is 19% below the current price. Whether Yatharth Hospital fits your portfolio depends on your time horizon, position size and risk appetite. Consult a SEBI-registered advisor before investing, as this article is not investment advice.
What are the bull case target and downside risk level for Yatharth Hospital shares?
Ans. The bull case in the Yatharth Hospital share price target for 2027 is Rs 1,398, which assumes 18.2% EPS growth and a PE of 62.73, a 15% re-rating from today’s multiple. That is 37.4% above the current price and above the 52-week high of Rs 1,184.00, so the stock would have to set a fresh 52-week high. The downside risk level is Rs 823, which assumes flat EPS and a PE of 43.64, 20% lower than today. It sits 19.1% below the current price and above the 52-week low of Rs 538.25, and it marks a risk to watch, not a target.
What are the main risks to the Yatharth Hospital price target?
Ans. Four risks matter most for the Yatharth Hospital share price target: slower revenue or profit growth, a PE de-rating, thin liquidity or size risk, and weakness in the broader market. With a market capitalisation of Rs 9,908 crore, the stock can move sharply on small volumes, and exits can take longer than entries. A fall to the downside-risk PE of 43.64 would cut the price even if earnings hold.
What is the PE ratio of Yatharth Hospital and how does it compare with the industry?
Ans. The PE ratio of Yatharth Hospital is 54.55, against an industry PE of 63.24, which is a discount to the industry. Price to book is 5.28 and return on equity is 10.16%, and the PE equals an earnings yield of 1.8%. The base case holds the PE unchanged, so the Yatharth Hospital share price target moves only with earnings, while the bull and downside scenarios change the multiple by +15% and -20%.
Who owns Yatharth Hospital, and what is the promoter holding?
Ans. Promoters held 55.80% of Yatharth Hospital in September 2026. FII held 7.05%, DII held 10.94% and the public held 26.21%. Together the two institutional groups hold 17.99%. Shareholding is filed every quarter, so it is worth rechecking after each result.
What were Yatharth Hospital’s latest quarterly results?
Ans. In the September 2026 quarter, Yatharth Hospital reported revenue of Rs 436.44 crore (up 51.1% year on year) and net profit of Rs 48.46 crore (up 17.5%). For comparison, FY26 full-year revenue growth was 37.5% and net profit moved up 30.5%. Each new quarter either supports or weakens the EPS growth of 12.2% assumed in the base case.
